Artificial Intelligence in Healthcare: From Predictive Models to Generative, Multimodal, and Agentic AI.

IF 4.4 3区 医学 Q2 ENGINEERING, BIOMEDICAL
İsmail Baydili, Burak Tasci, Gülay Tasci, Sengul Dogan, Turker Tuncer
{"title":"Artificial Intelligence in Healthcare: From Predictive Models to Generative, Multimodal, and Agentic AI.","authors":"İsmail Baydili, Burak Tasci, Gülay Tasci, Sengul Dogan, Turker Tuncer","doi":"10.3390/bioengineering13101175","DOIUrl":null,"url":null,"abstract":"<p><p>Artificial intelligence (AI) is increasingly used across the diagnostic pathway, from screening and disease detection to differential diagnosis, prognostic stratification, and treatment-response assessment. This narrative review examines predictive, generative, multi-modal, and agentic AI through a diagnostic-science lens and evaluates the evidence required for translation into clinical practice. Predictive models can identify complex patterns in images, physiological signals, laboratory data, and electronic health records, but high retrospective accuracy does not establish diagnostic utility. Clinical validity and utility depend on the intended use, target population, disease spectrum and prevalence, reference standard, operating threshold, calibration, and the consequences of false-positive and false-negative results. Generative AI may support problem representation, differential diagnosis, information synthesis, and documentation, yet fluent outputs can omit critical alternatives, amplify false premises, or convey unjustified certainty. Multimodal systems may better reflect clinical reasoning by integrating imaging, text, signals, pathology, and molecular data, but they must demonstrate incremental value over the best single-modality test and remain robust to missing data. Agentic systems can coordinate evidence retrieval, test selection, and sequential workflows, thereby increasing the need for bounded permissions, auditability, error recovery, and human escalation. Across all paradigms, a credible pathway to diagnostic implementation requires independent external and prospective validation, representative consecutive patients, subgroup analysis, workflow and human-AI evaluation, clinical impact studies, and post-deployment surveillance. The field should therefore be judged not by model capability alone, but by whether AI measurably improves diagnostic yield, timeliness, safety, equity, and patient-relevant outcomes in real care settings.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"13 10","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2026-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13701811/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering13101175","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Artificial intelligence (AI) is increasingly used across the diagnostic pathway, from screening and disease detection to differential diagnosis, prognostic stratification, and treatment-response assessment. This narrative review examines predictive, generative, multi-modal, and agentic AI through a diagnostic-science lens and evaluates the evidence required for translation into clinical practice. Predictive models can identify complex patterns in images, physiological signals, laboratory data, and electronic health records, but high retrospective accuracy does not establish diagnostic utility. Clinical validity and utility depend on the intended use, target population, disease spectrum and prevalence, reference standard, operating threshold, calibration, and the consequences of false-positive and false-negative results. Generative AI may support problem representation, differential diagnosis, information synthesis, and documentation, yet fluent outputs can omit critical alternatives, amplify false premises, or convey unjustified certainty. Multimodal systems may better reflect clinical reasoning by integrating imaging, text, signals, pathology, and molecular data, but they must demonstrate incremental value over the best single-modality test and remain robust to missing data. Agentic systems can coordinate evidence retrieval, test selection, and sequential workflows, thereby increasing the need for bounded permissions, auditability, error recovery, and human escalation. Across all paradigms, a credible pathway to diagnostic implementation requires independent external and prospective validation, representative consecutive patients, subgroup analysis, workflow and human-AI evaluation, clinical impact studies, and post-deployment surveillance. The field should therefore be judged not by model capability alone, but by whether AI measurably improves diagnostic yield, timeliness, safety, equity, and patient-relevant outcomes in real care settings.

医疗保健中的人工智能:从预测模型到生成、多模态和代理人工智能。
人工智能(AI)越来越多地应用于诊断途径,从筛查和疾病检测到鉴别诊断、预后分层和治疗反应评估。这篇叙述性综述通过诊断科学的视角考察了预测性、生成性、多模态和代理人工智能,并评估了转化为临床实践所需的证据。预测模型可以识别图像、生理信号、实验室数据和电子健康记录中的复杂模式,但高回顾性准确性并不能建立诊断效用。临床有效性和效用取决于预期用途、目标人群、疾病谱系和患病率、参考标准、操作阈值、校准以及假阳性和假阴性结果的后果。生成式人工智能可以支持问题表示、鉴别诊断、信息合成和文档编制,但流畅的输出可能会忽略关键的替代方案,放大错误的前提,或传达不合理的确定性。通过整合影像、文本、信号、病理和分子数据,多模态系统可能更好地反映临床推理,但它们必须比最好的单模态测试显示出增加的价值,并对缺失的数据保持稳健。代理系统可以协调证据检索、测试选择和顺序工作流,从而增加了对有限权限、可审计性、错误恢复和人工升级的需求。在所有范例中,实现诊断的可靠途径需要独立的外部和前瞻性验证、具有代表性的连续患者、亚组分析、工作流程和人类-人工智能评估、临床影响研究以及部署后监测。因此,不应仅通过模型能力来判断该领域,而应通过人工智能是否在实际护理环境中显著提高诊断产量、及时性、安全性、公平性和与患者相关的结果来判断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bioengineering
Bioengineering Chemical Engineering-Bioengineering
CiteScore
4.00
自引率
8.70%
发文量
661
期刊介绍: Aims Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal: ● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings. ● Manuscripts regarding research proposals and research ideas will be particularly welcomed. ● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material. ● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds. Scope ● Bionics and biological cybernetics: implantology; bio–abio interfaces ● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices ● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc. ● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology ● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering ● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation ● Translational bioengineering
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书